CYTOKINE LEVELS IN THE CEREBROSPINAL-FLUID AND SERUM OF PATIENTS WITH MULTIPLE-SCLEROSIS

被引:304
作者
MAIMONE, D
GREGORY, S
ARNASON, BGW
REDER, AT
机构
[1] UNIV CHICAGO, DEPT NEUROL, BOX 425, 5841 S MARYLAND AVE, CHICAGO, IL 60637 USA
[2] UNIV CHICAGO, DEPT MED, CHICAGO, IL 60637 USA
[3] UNIV CHICAGO, BRAIN RES INST, CHICAGO, IL 60637 USA
关键词
MULTIPLE SCLEROSIS; INTERLEUKIN-1; TUMOR NECROSIS FACTOR; INTERLEUKIN-6; CEREBROSPINAL FLUID; CYTOKINE;
D O I
10.1016/0165-5728(91)90073-G
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin (IL) 1-beta, tumor necrosis factor alpha (TNF-alpha), and IL-6 are cytokines which mediate cellular responses during immune activation and inflammation. In multiple sclerosis (MS) they might be responsible for T-cell activation (IL-1-beta), for demyelination (TNF-alpha), and for immunoglobulin (Ig) synthesis (IL-6) within the central nervous system. We studied IL-1-beta, TNF-alpha, and IL-6 levels in the cerebrospinal fluid (CSF) of 34 patients with MS, 43 patients with non-inflammatory neurological diseases (NIND), and 19 patients with inflammatory neurological diseases (IND). IL-6 was found in the CSF of 29% of MS, 7% of NIND, and 47% of IND patients. TNF-alpha was detected in the CSF of 23% of MS, 7% of NIND, and 29% of IND. CSF IL-6 and TNF-alpha levels were significantly higher in MS and IND than in NIND. IL-1-beta was rarely detected in the CSF of any group. At least one cytokine was detected in 52% of MS CSF, 11% of NIND CSF, and 64% of IND CSF. In MS patients, no relationship was observed between the incidence or the amount of intrathecal IgG synthesis or oligoclonal bands and the presence of any cytokine. We also evaluated cytokine levels in paired sera from 11 MS and 13 NIND patients. Low levels of IL-6 were detected in most sera from MS and NIND patients. TNF-alpha was detected in only two MS sera, and IL-1-beta was undetectable in any sample. Our results indicate that increased CSF levels of the cytokines IL-6 and TNF-alpha occur frequently in MS and IND, but there is no obvious relationship to intrathecal Ig synthesis.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 46 条
  • [1] PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES
    AARDEN, LA
    DEGROOT, ER
    SCHAAP, OL
    LANSDORP, PM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) : 1411 - 1416
  • [2] ACTION OF RECOMBINANT HUMAN INTERLEUKIN-6, INTERLEUKIN-1-BETA AND TUMOR NECROSIS FACTOR-ALPHA ON THE MESSENGER-RNA INDUCTION OF ACUTE-PHASE PROTEINS
    ANDUS, T
    GEIGER, T
    HIRANO, T
    KISHIMOTO, T
    HEINRICH, PC
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (05) : 739 - 746
  • [3] ARNASON BGW, 1991, DISEASES NERVOUS SYS
  • [4] TUMOR NECROSIS FACTOR-ALPHA ENHANCES INTERFERON-GAMMA-MEDIATED CLASS-II ANTIGEN EXPRESSION ON ASTROCYTES
    BENVENISTE, EN
    SPARACIO, SM
    BETHEA, JR
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1989, 25 (2-3) : 209 - 219
  • [5] INTERLEUKIN-1 ACTS ON CULTURED HUMAN VASCULAR ENDOTHELIUM TO INCREASE THE ADHESION OF POLYMORPHONUCLEAR LEUKOCYTES, MONOCYTES, AND RELATED LEUKOCYTE CELL-LINES
    BEVILACQUA, MP
    POBER, JS
    WHEELER, ME
    COTRAN, RS
    GIMBRONE, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) : 2003 - 2011
  • [6] MULTIPLE BIOLOGICAL-ACTIVITIES OF HUMAN RECOMBINANT INTERLEUKIN-1
    DINARELLO, CA
    CANNON, JG
    MIER, JW
    BERNHEIM, HA
    LOPRESTE, G
    LYNN, DL
    LOVE, RN
    WEBB, AC
    AURON, PE
    REUBEN, RC
    RICH, A
    WOLFF, SM
    PUTNEY, SD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) : 1734 - 1739
  • [7] TUMOR-NECROSIS-FACTOR (CACHECTIN) IS AN ENDOGENOUS PYROGEN AND INDUCES PRODUCTION OF INTERLEUKIN-1
    DINARELLO, CA
    CANNON, JG
    WOLFF, SM
    BERNHEIM, HA
    BEUTLER, B
    CERAMI, A
    FIGARI, IS
    PALLADINO, MA
    OCONNOR, JV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (06) : 1433 - 1450
  • [8] DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI [10.1016/s0065-2776(08)60642-2, 10.1016/S0065-2776(08)60642-2, DOI 10.1016/S0065-2776(08)60642-2]
  • [9] DURUM SK, 1989, FUNDAMENTAL IMMUNOLO, P639
  • [10] FARRAR WL, 1987, J IMMUNOL, V139, P459